Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference45 articles.
1. Bevacizumab for the treatment of glioblastoma;MJ Gil-Gil;Clin Med Insights Oncol,2013
2. The 2007 WHO classification of tumours of the central nervous system;DN Louis;Acta Neuropathol,2007
3. Bevacizumab alone and in combination with Irinotecan in recurrent glioblastoma;HS Friedman;J Clin Oncol,2009
4. Phase II trial of single-agent Bevacizumab followed by Bevacizumab plus Irinotecan at tumor progression in recurrent glioblastoma;TN Kreisl;J Clin Oncol,2009
5. RTOG 0825: Phase III double-blind placebo-controlled trial evaluating Bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM);MR Gilbert;J Clin Oncol,2013
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression;Cell Communication and Signaling;2024-05-13
2. Integrative Magnetic Resonance Imaging and Metabolomic Characterization of a Glioblastoma Rat Model;Brain Sciences;2024-04-23
3. Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain Tumors;Cancers;2024-01-30
4. Tracking Therapy Response in Glioblastoma Using 1D Convolutional Neural Networks;Cancers;2023-08-07
5. Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities;Lipids in Health and Disease;2023-08-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3